Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjmed.2013.09.018PMID 24384100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia.

  2012cited by this paper
• Clinical practice

  2011cited by this paper
• Prevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adults.

  2011cited by this paper
• Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.

  2011cited by this paper
• Major Lipids, Apolipoproteins, and Risk of Vascular Disease

  2010cited by this paper
• Dyslipidemia and cardiovascular risk: the importance of early prevention.

  2009cited by this paper
• All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study.

  2009cited by this paper
• Major lipids, apolipoproteins, and risk of vascular disease.

  2009cited by this paper
• Acute Pancreatitis in a Cohort of 129 Patients Referred for Severe Hypertriglyceridemia

  2008cited by this paper
• Lipoprotein Management in Patients With Cardiometabolic Risk

  2008cited by this paper
• Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.

  2007cited by this paper
• Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.

  2007cited by this paper
• [Non-fasting triglycerides and risk of for myocardial infarction and death among women and men].

  2007cited by this paper
• Clinical practice. Hypertriglyceridemia.

  2007cited by this paper
• Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men

  2007cited by this paper
• Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men

  2007cited by this paper
• Hypertriglyceridemia-induced pancreatitis: A case-based review.

  2006cited by this paper
• Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data

  2005cited by this paper
• Hypertriglyceridemia as a cardiovascular risk factor.

  1998cited by this paper
• Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies

  1996cited by this paper
• Primary type V hyperlipoproteinemia. A descriptive study in 32 families.

  1977cited by this paper
• Early coronary atherosclerosis in primary type V hyperlipoproteinemia.

  1971cited by this paper
• CASE REPORT pancreatitis: A case-based review

  year unknowncited by this paper

• Prevention and treatment of hypertriglyceridemia-mediated acute pancreatitis: A narrative review.

  2025cites this paper
• Safety and efficacy of antisense oligonucleotides on triglyceride, apolipoprotein C-III, and other lipid parameters levels in hypertriglyceridemia; a network meta-analysis of randomized controlled trials

  2025cites this paper
• Efficacy and safety of intensive triglyceride-lowering therapy on reducing recurrence of hypertriglyceridemia-associated pancreatitis (REDUCE): protocol for a multicentre, randomised controlled trial

  2025cites this paper
• Rates of acute pancreatitis and cardiovascular events among adults with severe or extreme hypertriglyceridemia in US clinical practice

  2025cites this paper
• Genetic determinants of pancreatitis risk in hypertriglyceridemia

  2024cites this paper
• Turkish Society of Gastroenterology: Pancreas Working Group, Acute Pancreatitis Committee Consensus Report

  2024cites this paper
• A population-based cohort study on risk factors for acute pancreatitis: A comparison by age group.

  2023cites this paper
• The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial

  2023cites this paper
• Triglyceride Clearance in Hypertriglyceridemic Pancreatitis: Time-course and its implications for management.

  2023cites this paper
• RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia.

  2023cites this paper
• Measurement of paraoxonase-1, visfatin levels in Iraqi diabetic and diabetic with hypothyroidism

  2022cites this paper
• Hypertriglyceridemia induced acute pancreatitis: 4 years’ experience from a tertiary care institute and quick literature review

  2022cites this paper
• American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.

  2022cites this paper
• Angiopoietin-Like Protein Responses to Pecan-Enriched Diets Versus a Nut-Excluded Diet

  2022cites this paper
• Prevalence, severity and management of hypertriglyceridemia-associated pancreatitis; A 7-year retrospective cohort study at canadian quaternary care hospitals.

  2022cites this paper
• Elevated Serum Triglycerides are Associated with Ketosis-Prone Type 2 Diabetes in Young Individuals

  2021cites this paper
• Secondary Causes of Hypertriglyceridemia are Prevalent Among Patients Presenting With Hypertriglyceridemia Induced Acute Pancreatitis.

  2021cites this paper
• Acute consumption of pecans decreases angiopoietin-like protein-3 in healthy males: a secondary analysis of randomized controlled trials.

  2021cites this paper
• DMSO_A_296085 497..504

  2021cites this paper
• Pecan-Enriched Diets Alter Cholesterol Profiles and Triglycerides in Adults at Risk for Cardiovascular Disease in a Randomized, Controlled Trial.

  2021cites this paper
• Efficacy of a micronized, nanocrystal fenofibrate formulation in treatment of hyperlipidemia in dogs

  2021cites this paper
• Acute Relapsing Pancreatitis

  2021cites this paper
• Current Diagnosis and Management of Primary Chylomicronemia

  2021cites this paper
• Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

  2021cites this paper
• Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.

  2020cites this paper
• CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY.

  2020cites this paper
• Clinical features and outcomes of hypertriglyceridemia-induced acute pancreatitis: Propensity score matching analysis from a prospective acute pancreatitis registry.

  2020cites this paper
• Hypertriglyceridemic pancreatitis.

  2020cites this paper
• A Comprehensive Update on the Chylomicronemia Syndrome

  2020cites this paper
• Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks

  2019cites this paper
• New Advances in the Treatment of Acute Pancreatitis

  2019cites this paper
• Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome.

  2019cites this paper
• Severe Hypertriglyceridemia-Related Pancreatitis: Characteristics and Predictors of Recurrence

  2019cites this paper
• 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2019cites this paper
• Evaluation of OM3-PL/FFA Pharmacokinetics After Single and Multiple Oral Doses in Healthy Volunteers.

  2019cites this paper
• DMSO_A_188856 2041..2052

  2019cites this paper
• 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2019cites this paper
• MICT or HIIT ± RT Programs for Altering Body Composition in Postmenopausal Women.

  2019cites this paper
• Suboptimal management of hypertriglyceridemia in the outpatient setting is associated with the recurrent pancreatitis

  2019influential citation
• Low-Grade Inflammation in the Association between Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis: A Study of More Than 115000 Individuals from the General Population.

  2019cites this paper
• A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States.

  2019cites this paper
• Experimental therapies targeting apolipoprotein C-III for the treatment of hyperlipidemia – spotlight on volanesorsen

  2019cites this paper
• CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.

  2019cites this paper
• A 7-day high-PUFA diet reduces angiopoietin-like protein 3 and 8 responses and postprandial triglyceride levels in healthy females but not males: a randomized control trial

  2019cites this paper
• Ekstrak Semanggi Air terhadap Aktivitas Enzim Lipoprotein Lipase pada

  2018cites this paper
• Clinical features and outcomes of severe, very severe, and extreme hypertriglyceridemia in a regional health service.

  2018cites this paper
• Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management

  2018cites this paper
• The Role of Endotherapy in Recurrent Acute Pancreatitis.

  2018cites this paper
• Uncomplicated Acute Pancreatitis: Evidenced-Based Management Decisions.

  2018cites this paper
• Effect of fenofibrate in 1113 patients at low-density lipoprotein cholesterol goal but high triglyceride levels: Real-world results and factors associated with triglyceride reduction

  2018cites this paper
• Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanisms.

  2018cites this paper
• Update in Pediatric Gastroenterology, Hepatology and Nutrition

  2018cites this paper
• An Update on Hypertriglyceridemia-Induced Acute Pancreatitis

  2018cites this paper
• CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.

  2017cites this paper
• Hypertriglyceridemic acute pancreatitis in emergency department: Typical clinical features and genetic variants

  2017cites this paper
• Epidemiology of Recurrent Acute and Chronic Pancreatitis: Similarities and Differences

  2017cites this paper
• Hypertriglyceridemia-Induced Acute Pancreatitis

  2017cites this paper
• Toxic-metabolic Risk Factors in Pediatric Pancreatitis: Recommendations for Diagnosis, Management, and Future Research

  2016cites this paper
• A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids

  2016cites this paper
• Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis.

  2016cites this paper
• CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

  2016cites this paper
• Is triglyceride therapy worth the effort?

  2015cites this paper
• Medical nutrition therapy is the essential cornerstone for effective treatment of "refractory" severe hypertriglyceridemia regardless of pharmaceutical treatment: Evidence from a Lipid Management Program.

  2015cites this paper
• Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.

  2015cites this paper
• Risk Assessment and Guidelines for the Management of High Triglycerides

  2015influential citation
• A Comparative Overview of Prescription Omega-3 Fatty Acid Products.

  2015cites this paper
• American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

  2015cites this paper
• Current knowledge of hypertriglyceridemic pancreatitis.

  2014cites this paper